Preeclampsia and future cardiovascular risk

References

• Miller TD, Balady GJ, Fletcher GF. Exercise and its role in the prevention and rehabilitation of cardiovascular disease. Ann. Behav. Med.19(3), 220–229 (1997).
   PubMed Web of Science ®Google Scholar
• Mosca L, Appel LJ, Benjamin EJ et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation109(5), 672–693 (2004).
   PubMed Web of Science ®Google Scholar
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation106(25), 3143–3421 (2002).
   PubMed Web of Science ®Google Scholar
• Feldman R, Genest J. Global risk assessment in 2005: where do we stand? Expert Opin. Clin. Impact1(7), 3–5 (2005).
   Google Scholar
• Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am. J. Obstet. Gynecol.183(1), S1–S22 (2000).
   PubMed Web of Science ®Google Scholar
• Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ157(6), 715–725 (1997).
   PubMed Web of Science ®Google Scholar
• Brown MA, Hague WM, Higgins J et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust. NZ J. Obstet. Gynaecol.40(2), 133–138 (2000).
   PubMed Web of Science ®Google Scholar
• Allen VM. The effect of hypertensive disorders in pregnancy on perinatal outcomes: a population-based cohort study. National Library of Canada Ottawa (2002).
   Google Scholar
• von Dadelszen P, Magee LA, Lee SK et al. Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit. Care Med.30(8), 1883–1892 (2002).
   PubMed Web of Science ®Google Scholar
• Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension46(6), 1243–1249 (2005).
   PubMed Web of Science ®Google Scholar
• Roberts JM, Lain KY. Recent Insights into the pathogenesis of pre-eclampsia. Placenta23(5), 359–372 (2002).
   PubMed Web of Science ®Google Scholar
• Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the ‘chicken-and-egg’ question. Endocrinology145(11), 4835–4837 (2004).
   PubMed Web of Science ®Google Scholar
• Redman CWG. The placenta, pre-eclampsia and chronic villitis. In: The Human Placenta. Redman CWG, Sargent ILSP (Eds). Blackwell Scientific, Oxford, UK, 433–467 (1993).
   Google Scholar
• Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Br. Med. J.325(7356), 157–160 (2002).
   PubMed Web of Science ®Google Scholar
• Ness RB, Hubel CA. Risk for coronary artery disease and morbid preeclampsia: a commentary. Ann. Epidemiol.15(9), 726–733 (2005).
   PubMed Web of Science ®Google Scholar
• Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis175(2), 189–202 (2004).
   PubMed Web of Science ®Google Scholar
• James PR, Nelson-Piercy C. Management of hypertension before, during, and after pregnancy. Heart90(12), 1499–1504 (2004).
   Google Scholar
• von Dadelszen P, Magee LA, Krajden M et al. Levels of antibodies against cytomegalovirus and Chlamydophila pneumoniae are increased in early onset pre-eclampsia. Br. J. Obstet. Gynaecol.110(8), 725–730 (2003).
   Google Scholar
• von Dadelszen P, Magee LA. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction? Acta Obstet. Gynecol. Scand.81(7), 642–648 (2002).
   PubMed Web of Science ®Google Scholar
• De Wolf F, Robertson WB, Brosens I. The ultrastructure of acute atherosis in hypertensive pregnancy. Am. J. Obstet. Gynecol.123(2), 164–174 (1975).
   PubMed Web of Science ®Google Scholar
• Chesley LC, Annitto JE, Cosgrove RA. The remote prognosis of eclamptic women. Sixth periodic report. Am. J. Obstet. Gynecol.124, 446–459 (1978).
   Google Scholar
• Arnadottir GA, Geirsson RT, Arngrimsson R, Jonsdottir LS, Olafsson O. Cardiovascular death in women who had hypertension in pregnancy: a case–control study. Br. J. Obstet. Gynaecol.112(3), 286–292 (2005).
   Google Scholar
• Funai EF, Friedlander Y, Paltiel O et al. Long-term mortality after preeclampsia. Epidemiology16(2), 206–215 (2005).
   PubMed Web of Science ®Google Scholar
• Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart77(2), 154–158 (1997).
   PubMed Web of Science ®Google Scholar
• Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br. Med. J.323(7323), 1213–1217 (2001).
   PubMed Web of Science ®Google Scholar
• Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet. Gynecol. Scand.74(10), 772–776 (1995).
   PubMed Web of Science ®Google Scholar
• Kestenbaum B, Seliger SL, Easterling TR et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am. J. Kidney Dis.42(5), 982–989 (2003).
   PubMed Web of Science ®Google Scholar
• Pell JP, Smith GC, Walsh D. Pregnancy complications and subsequent maternal cerebrovascular events: a retrospective cohort study of 119,668 births. Am. J. Epidemiol.159(4), 336–342 (2004).
   PubMed Web of Science ®Google Scholar
• Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS), population-based retrospective cohort study. Lancet366(9499), 1797–1803 (2005).
   PubMed Web of Science ®Google Scholar
• Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet357(9273), 2002–2006 (2001).
   PubMed Web of Science ®Google Scholar
• Smith GD, Sterne J, Tynelius P, Lawlor DA, Rasmussen F. Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology16(4), 563–569 (2005).
   PubMedGoogle Scholar
• Wikstrom AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. Br. J. Obstet. Gynaecol.112(11), 1486–1491 (2005).
   Google Scholar
• Wilson BJ, Watson MS, Prescott GJ et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. Br. Med. J.326(7394), 845 (2003).
   PubMed Web of Science ®Google Scholar
• Mann JI, Doll R, Thorogood M, Vessey MP, Waters WE. Risk factors for myocardial infarction in young women. Br. J. Prev. Soc. Med.30(2), 94–100 (1976).
   PubMedGoogle Scholar
• Grady D, Herrington D, Bittner V et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA288(1), 49–57 (2002).
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA289(19), 2560–2572 (2003).
   PubMed Web of Science ®Google Scholar
• Khan NA, McAlister FA, Rabkin SW et al. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: part II – therapy. Can. J. Cardiol.22(7), 583–593 (2006).
   PubMed Web of Science ®Google Scholar
• Mosca L, Linfante AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation111(4), 499–510 (2005).
   PubMed Web of Science ®Google Scholar
• Rosentock IM. Historical origins of the health belief model. Health Ed. Monogr.2, 328–333 (1974).
   Google Scholar
• Ali Z, Alexis SD. Occurrence of diabetes mellitus after gestational diabetes mellitus in Trinidad. Diabetes Care13(5), 527–529 (1990).
   PubMed Web of Science ®Google Scholar
• Kaufmann RC, Schleyhahn FT, Huffman DG, Amankwah KS. Gestational diabetes diagnostic criteria: long-term maternal follow-up. Am. J. Obstet. Gynecol.172(2 Pt 1), 621–625 (1995).
   PubMed Web of Science ®Google Scholar
• Feig DS, Chen E, Naylor CD. Self-perceived health status of women three to five years after the diagnosis of gestational diabetes: a survey of cases and matched controls. Am. J. Obstet. Gynecol.178(2), 386–393 (1998).
   PubMed Web of Science ®Google Scholar
• Genest J, Frohlich J, Fodor G, McPherson R. Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update. CMAJ169(9), 921–924 (2003).
   PubMed Web of Science ®Google Scholar
• Scialli AR, Lione A. ACE inhibitors and major congenital malformations. N. Engl. J. Med.355(12), 1280 (2006).
   PubMedGoogle Scholar
• Clapp JF III, Kim H, Burciu B, Lopez B. Beginning regular exercise in early pregnancy: effect on fetoplacental growth. Am. J. Obstet. Gynecol.183(6), 1484–1488 (2000).
   PubMed Web of Science ®Google Scholar
• Rosenstock IM. Adoption and maintenance of lifestyle modifications. Am. J. Prev. Med.4(6), 349–352 (1988).
   PubMedGoogle Scholar
• Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med.344(18), 1343–1350 (2001).
   PubMed Web of Science ®Google Scholar
• Eddy DM, Schlessinger L, Kahn R. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann. Intern. Med.143(4), 251–264 (2005).
   PubMed Web of Science ®Google Scholar
• McTigue KM, Harris R, Hemphill B et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann. Intern. Med.139(11), 933–949 (2003).
   PubMed Web of Science ®Google Scholar
• Linne Y, Dye L, Barkeling B, Rossner S. Weight development over time in parous women – the SPAWN study – 15 years follow-up. Int. J. Obes. Relat. Metab. Disord.27(12), 1516–1522 (2003).
   PubMed Web of Science ®Google Scholar